Pharmaceutical
| Sat 19 Sep 2026
Munich, Sept. 18 -- Betta Pharmaceuticals has applied European patent for Pan-KRAS Inhibitor and Use Thereof in Medicines. Yang Xiang, Wu Wenmao, Lan Hong, Ding Lieming, Wang Wei, Zhang Zhan, Wu Hao, Tian Kai, Zhou Quan, Li Boyan, Zhou Yuzhen, Zhao Zhichang, Wang Jiabing, Li Shusen and Zhu Xiaoguan developed it.
The patent ap..